Cardinal Health, Inc. (LON:0HTG)
London · Delayed Price · Currency is GBP · Price in USD 213.10
+1.47 (0.69%)
At close: Jan 30, 2026
Cardinal Health Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 234,310 | 222,578 | 226,827 | 204,979 | 181,326 | 162,467 | |
Revenue Growth (YoY) | 4.39% | -1.87% | 10.66% | 13.04% | 11.61% | 6.24% |
Cost of Revenue | 225,725 | 214,410 | 219,413 | 198,105 | 174,842 | 155,689 |
Gross Profit | 8,585 | 8,168 | 7,414 | 6,874 | 6,484 | 6,778 |
Selling, General & Admin | 5,566 | 5,382 | 5,000 | 4,800 | 4,512 | 4,533 |
Amortization of Goodwill & Intangibles | 316 | 303 | 264 | 285 | 324 | 451 |
Operating Expenses | 5,882 | 5,685 | 5,264 | 5,085 | 4,836 | 4,984 |
Operating Income | 2,703 | 2,483 | 2,150 | 1,789 | 1,648 | 1,794 |
Interest Expense | -230 | -182 | -77 | -84 | -147 | -180 |
Currency Exchange Gain (Loss) | -22 | -22 | 19 | -2 | - | -8 |
Other Non Operating Income (Expenses) | 35 | 30 | 16 | -3 | -22 | 55 |
EBT Excluding Unusual Items | 2,486 | 2,309 | 2,108 | 1,700 | 1,479 | 1,661 |
Merger & Restructuring Charges | -452 | -375 | -195 | -95 | -101 | -114 |
Impairment of Goodwill | - | - | -675 | -1,200 | -2,100 | - |
Gain (Loss) on Sale of Investments | - | - | - | - | 2 | -2 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -60 |
Asset Writedown | -21 | -18 | 41 | -46 | 40 | -19 |
Legal Settlements | 145 | 185 | -78 | 304 | -94 | -1,129 |
Other Unusual Items | - | - | - | - | -10 | -14 |
Pretax Income | 2,158 | 2,101 | 1,201 | 663 | -784 | 323 |
Income Tax Expense | 552 | 532 | 348 | 332 | 153 | -289 |
Earnings From Continuing Operations | 1,606 | 1,569 | 853 | 331 | -937 | 612 |
Net Income to Company | 1,606 | 1,569 | 853 | 331 | -937 | 612 |
Minority Interest in Earnings | -11 | -8 | -1 | -1 | -1 | -1 |
Net Income | 1,595 | 1,561 | 852 | 330 | -938 | 611 |
Net Income to Common | 1,595 | 1,561 | 852 | 330 | -938 | 611 |
Net Income Growth | 24.61% | 83.22% | 158.18% | - | - | - |
Shares Outstanding (Basic) | 240 | 241 | 245 | 261 | 279 | 292 |
Shares Outstanding (Diluted) | 241 | 242 | 247 | 262 | 279 | 294 |
Shares Change (YoY) | -2.24% | -2.02% | -5.73% | -6.09% | -5.10% | 0.34% |
EPS (Basic) | 6.65 | 6.48 | 3.48 | 1.26 | -3.36 | 2.09 |
EPS (Diluted) | 6.63 | 6.45 | 3.45 | 1.26 | -3.37 | 2.08 |
EPS Growth | 27.25% | 86.96% | 173.81% | - | - | - |
Free Cash Flow | 4,452 | 1,850 | 3,251 | 2,363 | 2,788 | 2,029 |
Free Cash Flow Per Share | 18.51 | 7.64 | 13.16 | 9.02 | 9.99 | 6.90 |
Dividend Per Share | 2.033 | 2.027 | 2.007 | 1.988 | 1.968 | 1.940 |
Dividend Growth | 1.00% | 1.00% | 0.99% | 1.00% | 1.45% | 1.04% |
Gross Margin | 3.66% | 3.67% | 3.27% | 3.35% | 3.58% | 4.17% |
Operating Margin | 1.15% | 1.12% | 0.95% | 0.87% | 0.91% | 1.10% |
Profit Margin | 0.68% | 0.70% | 0.38% | 0.16% | -0.52% | 0.38% |
Free Cash Flow Margin | 1.90% | 0.83% | 1.43% | 1.15% | 1.54% | 1.25% |
EBITDA | 3,544 | 3,273 | 2,860 | 2,481 | 2,340 | 2,577 |
EBITDA Margin | 1.51% | 1.47% | 1.26% | 1.21% | 1.29% | 1.59% |
D&A For EBITDA | 841 | 790 | 710 | 692 | 692 | 783 |
EBIT | 2,703 | 2,483 | 2,150 | 1,789 | 1,648 | 1,794 |
EBIT Margin | 1.15% | 1.12% | 0.95% | 0.87% | 0.91% | 1.10% |
Effective Tax Rate | 25.58% | 25.32% | 28.98% | 50.08% | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.